Anti-lipolytic effects of beta-hydroxybutyrate.
D000273:Adipose Tissue / Q000378:metabolism; D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D000818:Animals; D000242:Cyclic AMP / Q000037:antagonists & inhibitors; D004822:Epididymis / Q000378:metabolism; D004837:Epinephrine / Q000037:antagonists & inhibitors; D005215:Fasting; D005230:Fatty Acids, Nonesterified / Q000096:biosynthesis*; D005934:Glucagon / Q000037:antagonists & inhibitors; D005990:Glycerol / Q000096:biosynthesis*; D006885:Hydroxybutyrates / Q000494:pharmacology*; D066298:In Vitro Techniques; D050356:Lipid Metabolism; D008297:Male; D013806:Theophylline / Q000037:antagonists & inhibitors; D013972:Thyrotropin / Q000378:metabolism
D005230:Fatty Acids, Nonesterified; D006885:Hydroxybutyrates; D000324:Adrenocorticotropic Hormone; D013972:Thyrotropin; D005934:Glucagon; D013806:Theophylline; D000242:Cyclic AMP; D005990:Glycerol; D004837:Epinephrine